Development and validation of a simple and easy-to-employ electronic algorithm for identifying clinical methicillin-resistant Staphylococcus aureus infection

Infection Control and Hospital Epidemiology

Volumn 35, Issue 6, 2014, Pages 692-698

  Branch Elliman, Westyn ^a,b,c   Strymish, Judith ^a,c,e   Gupta, Kalpana ^a,d,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Division of SCI Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; LINEZOLID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ARTICLE; BRONCHITIS; CONFIDENCE INTERVAL; HEALTH CARE COST; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PNEUMONIA; PUBLIC HEALTH; SENSITIVITY AND SPECIFICITY; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION; URINARY TRACT INFECTION; VALIDATION PROCESS; ALGORITHM; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MULTIVARIATE ANALYSIS; PUBLIC HOSPITAL; RISK; STAPHYLOCOCCAL INFECTIONS; UNITED STATES; VALIDATION STUDY;

ALGORITHMS; CONFIDENCE INTERVALS; HOSPITALS, VETERANS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MULTIVARIATE ANALYSIS; ODDS RATIO; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 84899822661     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/676437     Document Type: Article

References (22)

1. Grota PG, Stone PW, Jordan S, Pogorzelska M, Larson E. Electronic surveillance systems in infection prevention: organizational support, program characteristics, and user satisfaction. Am J Infect Control 2010;38(7):509-514.
2. Greene L, Cain T, Khoury R, Krystofiak S, Patrick M, Streed S. APIC Position Paper: The Importance of Surveillance Technologies in the Prevention of Healthcare-Associated Infections (HAIs). 2009. http://www.apic.org/Resource_/TinyMceFileManager/Advocacy-PDFs/Surveillance_Technologies_position_paper_2009-5_29_09.pdf. Accessed April 2, 2013.
3. Tracy LA, Furuno JP, Harris AD, Singer M, Langenberg P, Rogh-mann MC. Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008. Emerg Infect Dis 2011;17(3):441-448.
4. Schweizer ML, Eber MR, Laxminarayan R, et al. Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staph-ylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol 2011;32(2): 148-154.
5. Schaefer MK, Ellingson K, Conover C, et al. Evaluation of International Classification of Diseases, Ninth Revision, Clinical Modification codes for reporting methicillin-resistant Staphylo-coccus aureus infections at a hospital in Illinois. Infect Control Hosp Epidemiol 2010;31(5):463-468.
6. Jones M, DuVall SL, Spuhl J, Samore MH, Nielson C, Rubin M. Identification of methicillin-resistant Staphylococcus aureus within the nation's Veterans Affairs medical centers using natural language processing. BMC Med Inform Decis Mak 2012;12:34.
7. Chalfine A, Cauet D, Lin WC, et al. Highly sensitive and efficient computer-assisted system for routine surveillance for surgical site infection. Infect Control Hosp Epidemiol 2006;27(8):794-801.
8. Wright MO, Perencevich EN, Novak C, Hebden JN, Standiford HC, Harris AD. Preliminary assessment of an automated surveillance system for infection control. Infect Control Hosp Epidemiol 2004;25(4):325-332.
9. Furuno JP, Schweizer ML, McGregor JC, Perencevich EN. Economics of infection control surveillance technology: cost-effective or just cost? Am J Infect Control 2008;36(suppl 3):S12-S17.
10. Leal J, Laupland KB. Validity of electronic surveillance systems: a systematic review. J Hosp Infect 2008;69(3):220-229.
11. Spolaore P, Pellizzer G, Fedeli U, et al. Linkage of microbiology reports and hospital discharge diagnoses for surveillance of surgical site infections. J Hosp Infect 2005;60(4):317-320.
12. Bolon MK, Hooper D, Stevenson KB, et al. Improved surveillance for surgical site infections after orthopedic implantation procedures: extending applications for automated data. Clin Infect Dis 2009;48(9):1223-1229.
13. Yokoe DS, Noskin GA, Cunnigham SM, et al. Enhanced identification of postoperative infections among inpatients. Emerg Infect Dis 2004;10(11):1924-1930.
14. Gupta K, Martinello RA, Young M, Strymish J, Cho K, Lawler E. MRSA nasal carriage patterns and the subsequent risk of conversion between patterns, infection, and death. PLoS ONE 2013;8(1):e53674.
15. Center for Drug Evaluation and Research, US Food and Drug Administration. Guidance for Industry Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment. Federal Register. 2010. http://www.fda.gov/downloads/Drugs/./Guidances/ucm071185.pdf. Accessed April 3, 2013.
16. File TM Jr, Low DE, Eckburg PB, et al. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, mul-ticenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis 2010;51(12):1395-1405.
17. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE; Infectious Diseases Society of America, Food and Drug Administration. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis 1992;15(suppl 1):S216-S227.
18. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11):996-1011.
19. Bureau of Labor Statistics, US Department of Labor. Occupational Outlook Handbook. 2012-3; 2012-13 edition. http://www.bls.gov/ooh/healthcare/registered-nurses.htm. Accessed April 2, 2013.
20. Kock R, Becker K, Cookson B, et al. Methicillin-resistant Staph-ylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010;15(41):19688.
21. Gupta K, Macintyre A, Vanasse G, Dembry LM. Trends in prescribing beta-lactam antibiotics for treatment of community-associated methicillin-resistant Staphylococcus aureus infections. J Clin Microbiol 2007;45(12):3930-3934.
22. Gastmeier P, Brauer H, Hauer T, Schumacher M, Daschner F, Ruden H. How many nosocomial infections are missed if identification is restricted to patients with either microbiology reports or antibiotic administration? Infect Control Hosp Epidemiol 1999;20(2):124-127.